NovoCure (NVCR) Operating Leases (2019 - 2026)
NovoCure (NVCR) posted Operating Leases of $37.5 million for Q2 2026, down 4.94% sequentially from $39.5 million in Q1 2026, and down 12.42% YoY from $42.9 million in Q2 2025.
NovoCure (NVCR) Operating Leases (2019 - 2026) Analysis & Trends
NovoCure has reported Operating Leases for 8 years, with the latest figure at $37.5 million in Q2 2026.
- Quarterly Operating Leases fell 12.42% year-over-year to $37.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $37.5 million (down 12.42% YoY) and the FY2025 annual result came in at $41.6 million, up 108.54% from the prior year.
- Operating Leases declined to $37.5 million in Q2 2026 per NVCR's latest filing, from $39.5 million in the prior quarter.
- Over five years, Operating Leases peaked at $42.9 million in Q2 2025 and troughed at $13.4 million in Q2 2022.
- A 5-year average of $26.9 million and a median of $21.9 million in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases decreased 27.17% in 2024, then soared 108.54% in 2025.
- Over 5 years, Operating Leases stood at $18.8 million in 2022, then jumped by 46.15% to $27.4 million in 2023, then fell by 27.17% to $20.0 million in 2024, then jumped by 108.54% to $41.6 million in 2025, then declined by 9.89% to $37.5 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $37.5 million, $39.5 million, and $41.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.53 Mn |
| Mar 31, 2026 | 39.48 Mn |
| Dec 31, 2025 | 41.65 Mn |
| Sep 30, 2025 | 42.68 Mn |
| Jun 30, 2025 | 42.85 Mn |
| Mar 31, 2025 | 40.31 Mn |
| Dec 31, 2024 | 19.97 Mn |
| Sep 30, 2024 | 21.14 Mn |
| Jun 30, 2024 | 21.73 Mn |
| Mar 31, 2024 | 25.61 Mn |
| Dec 31, 2023 | 27.42 Mn |
| Sep 30, 2023 | 22.05 Mn |
| Jun 30, 2023 | 20.33 Mn |
| Mar 31, 2023 | 19.97 Mn |
| Dec 31, 2022 | 18.76 Mn |
| Sep 30, 2022 | 14.83 Mn |
| Jun 30, 2022 | 13.38 Mn |
| Mar 31, 2022 | 14.81 Mn |
| Dec 31, 2021 | 13.00 Mn |
| Sep 30, 2021 | 11.48 Mn |